Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2011
01/26/2011CN101245394B Primer and probe of west nile virus and real time RT-PCR detection reagent kit with one-step method
01/26/2011CN101205542B Construction method of shRNA expression carrier for inhibiting core1 beta1-3 galactosyltransferase and use thereof
01/26/2011CN101177689B Method for high-effective construction of T-carrier based on polymerase chain reaction
01/26/2011CN101173294B Gene tiny chain carrier, construction method and application of the same
01/26/2011CN101164624B Nucleic acids, polypeptides, and methods for modulating apoptosis
01/26/2011CN101161816B Plant expression carrier construction for divalent insect-resistant gene and transgenic plant acquiring method thereof
01/26/2011CN101139399B Fused protein restructuring target lethal leukemia cells and preparation method and use thereof
01/26/2011CN101130782B Construction method for producing 1,3-trimethylene glycol regrouping saccharomyces cerevisiae with glucose as substrate
01/26/2011CN101117637B Strict hypoxia targeting carrier and uses thereof
01/26/2011CN101092632B Transgenic fiber producing plants with increased expression of sucrose phosphate synthase
01/25/2011US7875780 Inbred corn line LLD20BM
01/25/2011US7875777 Plants and seeds of corn variety CV078625
01/25/2011US7875774 Plants and seeds of corn variety CV146461
01/25/2011US7875773 Plants and seeds of hybrid corn variety CH600622
01/25/2011US7875772 Plants and seeds of hybrid corn variety CH911371
01/25/2011US7875771 Maize variety PHH05
01/25/2011US7875770 Maize variety X7V604
01/25/2011US7875769 Soybean variety A1016497
01/25/2011US7875768 Soybean variety D5232543
01/25/2011US7875767 Soybean variety D5219547
01/25/2011US7875766 Soybean variety D5684792
01/25/2011US7875765 Soybean variety S06-02KG294679
01/25/2011US7875764 Nucleotide sequences mediating male fertility and method of using same
01/25/2011US7875763 Fructan biosynthetic enzymes
01/25/2011US7875762 Method of producing an exogenous protein in the egg of a chicken
01/25/2011US7875733 Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
01/25/2011US7875711 Compositions and methods for inhibiting expression of XBP-1 gene
01/25/2011US7875710 Nucleic acids encoding platelet derived growth factor receptor alpha (PDGFRA) activating mutations
01/25/2011US7875709 Nucleic acids encoding interleukin-18 mutants
01/25/2011US7875703 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases
01/25/2011US7875702 B7-H3 and B7-H4, novel immunoregulatory molecules
01/25/2011US7875677 Micellar drug delivery systems for hydrophobic drugs
01/25/2011US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide
01/25/2011US7875454 Exposing the tissue to ionizing radiation; administering a delivery vehicle, platelets; leukocytes; proteins or peptides of the active agent; treating neoplasms, cancers, tumors
01/25/2011US7875452 transient receptor potential (TRP) family of ion channels; recombinant vectors, host cells; high throughput screening, drug screening
01/25/2011US7875449 Oligonucleotide non-viral delivery systems
01/25/2011US7875445 Subtilases
01/25/2011US7875441 hybridization assay probes, helper probes, and/or amplification primers; kits
01/25/2011US7875439 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection
01/25/2011US7875438 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
01/25/2011US7875437 Expression vector comprising nucleotide sequences coding streptococcal surface protein for use in detection, prevention and treatment of microorganismal infection
01/25/2011US7875421 determining probiotic properties
01/25/2011US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis
01/25/2011US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders
01/25/2011US7875255 Highly dispersible inorganic nanoparticles with a low aggregation property, even though the nanoparticles are covered with labeled compounds; hydroxyapatite-modifiedpolyethyleneimine modified by biological labels such asenzymes, antibodies, colored proteins, fluoroproteins, DNA, RNA; antiagglomerants
01/25/2011CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
01/25/2011CA2545180C Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof
01/25/2011CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
01/25/2011CA2510446C Genes conferring herbicide resistance
01/25/2011CA2495743C Fusion proteins and methods of producing same
01/25/2011CA2480684C Host cells having improved cell survival properties and methods to generate such cells
01/25/2011CA2458842C Plant system for comprehensive gene function analysis with the use of full-length cdnas
01/25/2011CA2430182C Prokaryotically produced antibodies and uses thereof
01/25/2011CA2423068C Acoustic ejection of fluids from a plurality of reservoirs
01/25/2011CA2410000C Compositions and methods comprising plasmid dna for wound healing and for repairing and regenerating tissue
01/25/2011CA2392190C Method of constructing cell-fusion mutants of morbillivirus
01/25/2011CA2384425C Methods and compositions for delivery of pharmaceutical agents
01/25/2011CA2378519C Human cytokine receptor
01/25/2011CA2369826C Therapy of cardiac insufficiency
01/25/2011CA2356741C Novel rhodococcus bacterium, nitrilase gene, nitryl hydratase gene and amidase gene from rhodococcus bacterium, and process for producing carboxylic acids using them
01/25/2011CA2344467C Ucp4
01/25/2011CA2338186C Tumor necrosis factor-gamma
01/25/2011CA2333833C Specific binding molecules for scintigraphy,conjugates containing them and therapeutic method for treatment of angiogenesis
01/25/2011CA2331392C Coniothyrium minitans xylanase gene cxy1
01/25/2011CA2321089C Human homolog of the drosophila protein "fused"
01/25/2011CA2312208C Humanization of murine antibody
01/25/2011CA2295540C Improved anti-ige antibodies and method of improving polypeptides
01/25/2011CA2292378C A method of inhibiting cancer cell growth using a vector expressing prb2/p130
01/25/2011CA2281858C A method for making infectious, propagation defective tr339 virus particles and helper cells therefor
01/25/2011CA2236378C Recombinant sendai virus
01/25/2011CA2224309C Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
01/25/2011CA2199158C Seed-specific promoter from barley beta-amylase gene
01/25/2011CA2174098C Method of inducing and maintaining neuronal cells
01/22/2011CA2690651A1 Preservation of fetal nucleic acids in maternal plasma
01/20/2011WO2011009132A2 Methods and composition for isoprenoid diphosphate synthesis
01/20/2011WO2011009036A1 Soybean derived human thyroglobulin, methods of producing and applications thereof
01/20/2011WO2011008995A1 Modulation of factor 7 expression
01/20/2011WO2011008982A1 Treatment of neurological disorders
01/20/2011WO2011008959A1 Enhancement of cellular production through mechanotransduction
01/20/2011WO2011008947A2 Treatment and diagnosis of immune disorders
01/20/2011WO2011008904A1 Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
01/20/2011WO2011008857A1 SiRNA PHOSPHOLIPID CONJUGATE
01/20/2011WO2011008803A2 Novel δ9-elongase for production of polyunsaturated fatty acid-enriched oils
01/20/2011WO2011008735A1 Oral vaccines produced and administered using edible micro-organism
01/20/2011WO2011008730A2 Chemical modification of small hairpin rnas for inhibition of gene expression
01/20/2011WO2011008698A1 Plants with modified lignin content and methods for production thereof
01/20/2011WO2011008641A1 Methids of modulating angiogenesis and treatment of angiogenesis-related diseases
01/20/2011WO2011008545A2 Poly(ester ether amide)s and uses thereof
01/20/2011WO2011008541A2 Molecular markers and assay methods for characterizing cells
01/20/2011WO2011008530A2 Chimeric primers with hairpin conformations and methods of using same
01/20/2011WO2011008517A2 Immunoglobulin fc polypeptides
01/20/2011WO2011008510A2 Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase
01/20/2011WO2011008502A2 Isolation of unknown rearranged t-cell receptors from single cells
01/20/2011WO2011008348A2 Dual vector for inhibition of human immunodeficiency virus
01/20/2011WO2011008303A2 Designer collagens and uses thereof
01/20/2011WO2011008232A2 BIOSYNTHETIC ROUTES TO LONG-CHAIN a, w-HYDROXY ACIDS, DIACIDS AND THEIR CONVERSION TO OLIGOMERS AND POLYMERS
01/20/2011WO2011008231A2 Biotransformation using genetically modified candida
01/20/2011WO2011008171A1 Influenza detection method and kit therefor
01/20/2011WO2011008117A2 The use of a sirna oligonucleotide
01/20/2011WO2011008096A1 Regulation of zinc deficiency and tolerance in plants